Skeptical Raptor

@skepticalraptor.bsky.social

I use evidence-based science to shred bogus claims about health and medicine. Vaccines are safe and effective. Evolution is a fact. Supplements are a waste of money. I post articles at skepticalraptor.com

The US FDA has approved four COVID vaccines targeting the XFG variant for the 2026-2027 season, from Moderna, Pfizer/BioNTech, Novavax, and Sanofi. The vaccines are available for high-risk individuals; the CDC's lack of guidance will lead to confusion. buff.ly/W32vhHY

FDA approves four new COVID vaccines for the 2026-27 season

The US FDA has approved four COVID vaccines targeting the XFG variant for the 2026-2027 season, developed by Moderna, Pfizer and BioNTech, Novavax, and Sanofi. While the vaccines are available for…

skepticalraptor.com

The US FDA has approved four COVID vaccines targeting the XFG variant for the 2026-2027 season, from Moderna, Pfizer/BioNTech, Novavax, and Sanofi. The vaccines are available for high-risk individuals; the CDC's lack of guidance will lead to confusion. www.skepticalraptor.com/skepticalrap...

FDA approves four new COVID vaccines for the 2026-27 season

The US FDA has approved four COVID vaccines targeting the XFG variant for the 2026-2027 season, developed by Moderna, Pfizer and BioNTech, Novavax, and Sanofi. While the vaccines are available for hig...

skepticalraptor.com

A recent study indicates that recipients of the recombinant shingles vaccine (Shingrix) experience a lower incidence of future cardiovascular events compared to those who received the live-attenuated vaccine (Zostavax). buff.ly/iObgekA

Recombinant shingles vaccine improves cardiovascular outcomes

A recent study indicates that recipients of the recombinant shingles vaccine experience a lower future risk of cardiovascular events.

skepticalraptor.com

A recent study indicates that recipients of the recombinant shingles vaccine (Shingrix) experience a lower incidence of future cardiovascular events compared to those who received the live-attenuated vaccine (Zostavax). www.skepticalraptor.com/skepticalrap...

Recombinant shingles vaccine improves cardiovascular outcomes

A recent study indicates that recipients of the recombinant shingles vaccine experience a lower future risk of cardiovascular events.

skepticalraptor.com

A recent study on a peptide #vaccine targeting KRAS mutations demonstrates promising results for #pancreatic cancer treatment. It elicited T-cell responses in 90% of patients, demonstrating safety and response persistence for up to 2 years. buff.ly/bCbhVEd

Pancreatic cancer peptide vaccine shows promise in patients

A recent study on a peptide vaccine targeting KRAS mutations demonstrates promising results for pancreatic cancer treatment.

skepticalraptor.com